Emerging diagnostic methods and imaging modalities in cushing's syndrome

Area of Science:

• Endocrinology
• Diagnostic Medicine
• Medical Imaging

Background:

• Endogenous Cushing's syndrome (CS) results from prolonged glucocorticoid excess, necessitating timely diagnosis to prevent severe morbidity and mortality.
• Traditional diagnostic methods for CS have limitations in sensitivity, specificity, and managing fluctuating hormone levels, complicating accurate diagnosis.
• Differentiating Cushing's disease (CD) from ectopic ACTH secretion is challenging, often requiring invasive procedures due to limitations of conventional pituitary MRI.

Purpose of the Study:

• To review emerging diagnostic methods and imaging modalities for Cushing's syndrome (CS).
• To discuss the diagnostic accuracy, strengths, limitations, and clinical applicability of these newer techniques.
• To highlight advancements that may improve the definitive diagnosis of CS and its subtypes.

Main Methods:

• Review of novel biochemical assays, including scalp hair cortisol and cortisone analysis for long-term glucocorticoid exposure.
• Evaluation of advanced imaging techniques such as high-resolution 3T-MRI for detecting small pituitary adenomas.
• Assessment of functional imaging modalities like Gallium-68-tagged CRH-PET-CT for identifying ACTH-secreting adenomas and their functionality.

Main Results:

• Hair cortisol and cortisone analysis demonstrate high sensitivity and specificity in differentiating CS patients from controls.
• High-resolution 3T-MRI can detect pituitary microadenomas (as small as 2 mm) missed by conventional MRI.
• Functional imaging like Ga-68-CRH-PET-CT aids in delineating CD from ectopic ACTH secretion and false-positive MRI findings.

Conclusions:

• Emerging diagnostic methods, including hair analysis and advanced imaging, offer improved accuracy and reduce uncertainty in CS diagnosis.
• These newer techniques have the potential to provide more definitive diagnoses, guiding treatment decisions and potentially avoiding invasive procedures.
• Further clinical application of these advancements is expected to enhance the management of patients with Cushing's syndrome.